On July 10, 2015, the House of Representatives passed the 21st Century Cures Act (H.R. 6) with a unanimous vote and it went on to the US Senate for approval and implementation. The bill will speed up the approval process for drugs and healthcare devices, and spur biomedical innovation. If passed, it will significantly affect pharmaceutical research and healthcare.
Read this whitepaper to find out more about the 5 possible scenarios for the pharmaceutical sector after the inclusion of more technology-driven healthcare innovation and the introduction of additional personal data and information into health science.
